The medical industry is far from achieving racial health equity, according to a new report from Accenture. But it could be. The report, which outlines some of the stark racial health disparities still plaguing…
Continue Reading
Travere Therapeutics has won FDA approval for a drug that treats a rare autoimmune disorder that is typically first noticed as blood in the urine and can progress over time to end-stage kidney failure.
The…
Ashish Kachru, CEO, DataLinkThe new healthcare realm of value-based care (VBC), designed to reward healthcare providers with incentive payments for the quality of care and patient outcomes not simply the volume of services provided,…
Continue Reading
Top News
ONC publishes “Social Determinants of Health Information Exchange Toolkit.”
Reader Comments From NY CIO: “Re: Northwell Health. Word is it will announce its move to Epic and that it will bring a large…
Continue Reading
In the world of Healthcare, there isn’t much room for making guesses. When you’re in charge of someone’s well being, it is critical that all of your decisions are well thought through and based…
Continue Reading
Deidentifying data from wearable devices may not be enough to protect users’ privacy, according to a review of studies published in the Lancet Digital Health. The analysis focused on studies that evaluated whether individuals could…
Continue Reading
BroadbandOhio, a division of the Ohio Department of Development, selected OCHIN as its statewide telehealth administrator to help expand healthcare services for Ohio’s K-12 students.WHY IT MATTERS
The new initiative aims to help administrators in…
Harness the true power of the data!
Yes. That’s the ultimate goal of Business intelligence (BI).
BI has the potential to unlock endless possibilities for the healthcare industry to thrive.
In other words, data is evolving as a new diagnostic tool in healthcare.
That’s the reason, healthcare organizations, startups, enterprises, and individuals are…
Pete speaks with a lot of people who have a clinical background. They have done the hard work to be a doctor, a nurse, or an allied health provider. They go through the training, they get all the…
Continue Reading
A Moderna messenger RNA vaccine for influenza now has preliminary data from a pivotal study showing the shot prompted a strong immune response to the more common strains of the virus but fell short against less common strains.
The results reported Thursday are from one of two pivotal studies for the Moderna vaccine, mRNA-1010, which is assessing the shot for safety and immune response. A separate Phase 3 study is evaluating the shot for efficacy. Results from that study could come as early as next month. Moderna’s vaccine encodes hemagglutinin, a protein on the surface of the influenza virus that is also…
